chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Second shot 2 months, 5 days after the first shot.  No pain or problem with the first shot.
The patient immediately after being immunized suffered a vasovagal, her skin became cold and pale, she was estimated by the paramedic pulse 78 temperature 35.9 B/P 110/70 dextro 64 proceed to call Doctor and He suggests leaving her under observation for 30 minutes since the relative brought her something to eat. After 30 minutes, the vital signs are estimated for the re-evaluation at 9:00 pm, the results are notified to Doctor. B/P 100/80 Respirations 16 pulse 63 Dextro 79 The Doctor proceeds to discharge the patient at 9:00 pm.
Pt felt light headed and dizzy a few minutes after injection. She laid down and waited with her mother. She kept saying that her vision was "funny, like in a tunnel". She was monitored for about 30 minutes after injection before leaving clinic.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site tenderness in a 76-year-old female patient who received SHINGRIX (batch number 49R72, expiry date 13th March 2021) for prophylaxis. This case was associated with a product complaint. Concomitant products included SHINGRIX. On 16th January 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In January 2019, less than a week after receiving SHINGRIX and an unknown time after receiving SHINGRIX, the patient experienced injection site tenderness. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the injection site tenderness was not recovered/not resolved and the outcome of the pharmaceutical product complaint was unknown. It was unknown if the reporter considered the injection site tenderness to be related to SHINGRIX. Additional details were reported as follows: A day before the date of reporting, the patient received 2nd dose of SHINGRIX in the left deltoid. After receiving the 2nd dose of SHINGRIX, the patient experienced tenderness at the injection site. The reporter did not consent to follow up. This case was one of the 5 cases, reported by the same reporter.
23 yo female received Smallpox vaccine on 7 AUG 2016. Patient reported she developed a rash approx. day 13 post smallpox vaccination. Dermatitis characterized by small discrete scattered pruritic papules to shoulders, upper extremities, anterior lower extremities, and a few on her chest and under her bra. There are no pustules, vesicles, plaques. The dermatitis has been improving and pruritus has diminished. Papules are barely visible, but are palpable. Patient denies fever chills malaise headache, myalgia or arthralgia. Description of vaccine site, "looks great" (per medics) scab intact and no peripheral satellite areas. No new treatments and there has been no new identifiable exposures.
Adverse events: fever, fatigue, headache, injection site pain and redness. Onset of adverse events: next day of second dose. Duration of adverse events: 1 day. Currently pregnant. Estimated date of delivery: 11/2021.
Initial information received on 03-Oct-2018 regarding an unsolicited valid serious case received from a a Pharmacist. This case involves a 66 years old male patient who experienced profuse sweating, had a little bit of headache, became very light headed and passes out while he received vaccine FLUZONE HIGH DOSE. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. No concomitant therapies received. On 25-Sep-2018, the patient received a 0.5 ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UJ000AA and 28-MAR-2019) via unknown route in the left deltoid. On 25-Sep-2018, the patient developed a serious loss of consciousness 3 hours following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. This event was assessed as medically significant. On 25-Sep-2018, the patient developed a non-serious profuse sweating and became very light headed same day following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. On an unknown date (when patient went home), the patient developed a little bit of headache (latency unknown) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. It was reported that, patient got a FLUZONE HD shot, he went home went out for dinner about 3 hours later and passes out. Also he states that he started sweating and became very light headed with profuse sweating about 1/2 way through dinner - he then blacked out laying over on the booth. His friend shook him for about 10 seconds and then he came back awake. He states he felt ok after that except when got home he had a little bit of headache. Once home he relaxed and didn't take anything for the headache. He reports that he's never had any reaction to flu vaccine in the past, he didn't obtain any medical attention from EMS or his HCP and has been fine since then. No information about relevant tests reported. Final diagnosis was Mild headache, profuse sweating and loss of consciousness. As a corrective treatment patients friend shook him for about 10 seconds and then he came back awake and the patient did not take anything for headache. The patient recovered from reported events on an unknown date. List of documents held by sender: none. Sender's Comments: This case involves a 66 years old patient who experienced profuse sweating, light headedness and passes out 3 hours post vaccination with FLUZONE HIGH DOSE. Patient also had a little bit of headache. Time to onset is compatible. More details regarding patient's medical history, condition at the time of vaccination, vaccination technique, etiological workup and investigation reports to identify alternative etiology are needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Sunday I started feeling achy, had a headache and had the chills, but no fever, Monday I felt the same.  Tuesday I also felt that way, but also was nauseous. I vomited a few times, had a sore throat develop and diarrhea. Wednesday, I no longer had a headache, but still the chills, with vomiting and diarrhea.
Patient requested a bivalent COVID Pfizer booster shot but was given a monovalent one. The patient was contacted and informed about possibility of revaccination in 2 months.
I nearly died; This case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced near death experience (serious criteria GSK medically significant and life threatening). On an unknown date, the outcome of the near death experience was unknown.   The reporter considered the near death experience to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient nearly died from the first shot. The patient stated that, he/she would have to suffer with them because could not get the second.
At four am I stood up from using the bathroom and blood rushed to my head my ears began ringing very very loudly. I thought I would vomit or pass out. Thankfully it passed but then at 7 am I was very careful to stand up slowly and make no sudden movements but it happened again. I was seated this time when the loud ringing started in my ears, my vision went completely white and then I passed out. When I came to I had a splitting pounding headache for about 30 minutes. The rest of the day I had little to no energy and walking would leave me breathless.
I had a low grade temp of 99.8, chills, cough, and sore throat. The next day I received a positive COVID-19 test. I was prescribed Paxlovid. My symptoms progressed to headache and nausea. Within 48 hours of Paxlovid my symptoms resolved except fatigue.
PATIENT REFERS MUSCULAR HYPERTONIA (RIGID) IN EXTREMITIES AND FEVER.
The caller's boyfriend caught Covid-19 a few weeks ago; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (The caller's boyfriend caught Covid-19 a few weeks ago) in a 65-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (2nd dose), COVID-19 Vaccine (Dose 4), COVID-19 Vaccine (Dose 3) and PFIZER BIONTECH COVID-19 VACCINE (1st dose). Past adverse reactions to the above products included No adverse event with COVID-19 Vaccine, COVID-19 Vaccine, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    In 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In May 2023, the patient experienced COVID-19 (The caller's boyfriend caught Covid-19 a few weeks ago). At the time of the report, COVID-19 (The caller's boyfriend caught Covid-19 a few weeks ago) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. It was reported that patient had received 5 Covid -19 Vaccinations and was not sure about the third and fourth Covid-19 vaccines. Patient caught Covid-19 a few weeks ago. No treatment information was provided.   Reporter did not allow further contact
Right sided facial droop. It has not been treated by the doctor yet. He will be taken to the emergency room of the  hospital.
Immediately after all 3 shots had facial numbness. It was sensory loss only; all motor was intact. No other symptoms. After the first shot it lasted about 10 minutes; 2nd shot as bout 25 minutes. Numbness just gradually left. After 3rd shot the numbness was the same but I had lip numbness for 2 hours. They then started tingling similar to anesthetic wearing off after dental work. Then I was fine.
Pt received J&J yesterday. Pt started having fever, bodyaches and chills. Pt was SOB last night, but not now.
Arm was sore, not too bad; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain in extremity (received 1st dose on an unknown date and had sore arm, refer case US2022AMR015224).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient received a shot and his/her arm was sore for a few days, but not too bad. The reporter worth that comparing to these horror stories, which he/she was reading on this thread. The follow-up could not be possible as no contact details were available. The case was linked with case US2022AMR015237 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR015224:Same reporter. US-GLAXOSMITHKLINE-US2022AMR015237:Same reporter. Hearsay.
On 01/15/2021,  shot was received in upper left arm 01/16/2021 - noticed fatigue, fever, injection site pain, joint pain, chills 01/17/2021 - noticed lymph nodes under left arm were very swollen but soft (swelling size of a tennis ball) shooting pain, along with other symptoms. Limited use of left arm due to numbness and tingling when in use. 01/18/2021 - shooting pain in lymph node area along with burning and throbbing 01/19/2021 - swelling had decreased some.
had an allergic reaction to the COVID Vaccine; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "had an allergic reaction to the COVID Vaccine".  Additional information: Reporter wanted to know if a patient was eligible to take PAXLOVID if they had an allergic reaction to the COVID Vaccine. Patient took the Pfizer COVID-19 Vaccine. When asked if patient had more information about the patient, reporter stated that they will let the provider know that Pfizer wanted more information about the patient.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Cough; had the worst case of the flu; Initial information received on 04-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves adult patient of unknown gender who experienced cough and had the worst case of the flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for flu (influenza).  On an unknown date, the patient developed non-serious event of cough and the worst case of the flu (influenza) (unknown latency) following the administration of influenza vaccine.  No lab data was reported.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the events (Cough, had the worst case of the flu).  Outcome: Unknown for both events.
Pain in the calf and leg at nights/pain in leg when lay down at night; limping off and on; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the calf and leg at nights/pain in leg when lay down at night) and GAIT DISTURBANCE (limping off and on) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the calf and leg at nights/pain in leg when lay down at night) and GAIT DISTURBANCE (limping off and on). At the time of the report, PAIN IN EXTREMITY (Pain in the calf and leg at nights/pain in leg when lay down at night) and GAIT DISTURBANCE (limping off and on) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information were provided.
During post vaccine observation period (at about 20 min or so), patient began  complaining of feeling her heart beating fast, heavy feeling in chest which then progressed to "hard time breathing".  Patient was pale, c/o weakness.  911 was called and epi -pen 0.3mg IM to left thigh was administered.  911 came and treated patient.  She was stabilized and then wanted to go home rather than being transported to ER.
pt recv vax 19APR97 & 19APR97 pt devel a fever & less than 50 lesions that were described as moderate;No further details were provided;
16 year old patient received 1st dose of Moderna vaccination. Patient had no adverse outcomes.
pt recv vax 3MAR97 & 8MAR97 pt exp a fever of 104;
Redness & tenderness to (L) deltoid - 8-10 cm - fever 103.
Pt was seen on 6/8 for same issue, but it was 10 days post covid 19 pfizer vaccine #1.  Today, pt is here with similar symptoms but worse; rash covering face, neck, spreading over body; bil periorbital edema, facial edema.  Pt's second covid vaccine was 4 days ago. Today she was prescribed prednisone oral for 9 days and triamcinolone ointment.
KIDNEY PAIN; STOMACH PAIN; NAUSEA; HEADACHE; CHILLS; MIGRAINE; DISCONNECTED; JOINT PAIN; FEVER; BODY ACHES; DIZZY; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included kidney infection, and concurrent conditions included hypothyroidism. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch no was not reported ,The company is unable to performed follow up to request batch /Lot numbers. No concomitant medications were reported. On 02-APR-2021, the subject experienced fever. On 02-APR-2021, the subject experienced body aches. On 02-APR-2021, the subject experienced dizzy. On 02-APR-2021, the subject experienced fatigue. On 02-APR-2021, the subject experienced disconnected. On 02-APR-2021, the subject experienced joint pain. On an unspecified date, the subject experienced headache, kidney pain, stomach pain, nausea, chills, and migraine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fever, body aches, kidney pain, stomach pain, nausea, dizzy, fatigue, chills, disconnected, joint pain and migraine was not reported. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not known. On 23-SEP-2016 the patient was vaccinated with the yellow fever virus vaccine and then on 11-OCT-2016, patient was with M-M-R II. No adverse effect was reported. The outcome of inappropriate schedule of drug administration was unknown. Additional information has been requested.
Frozen shoulder; is still having problem moving her arm behind her head; This spontaneous case was reported by a consumer and describes the occurrence of PERIARTHRITIS (Frozen shoulder) and LIMB DISCOMFORT (is still having problem moving her arm behind her head) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIARTHRITIS (Frozen shoulder) and LIMB DISCOMFORT (is still having problem moving her arm behind her head). At the time of the report, PERIARTHRITIS (Frozen shoulder) was resolving and LIMB DISCOMFORT (is still having problem moving her arm behind her head) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by reporter. She has been taking vitamins to help with the numbness and she got steroid for the frozen shoulder. Some improvement with the neurological symptoms but with the shoulders, not so much.   This case was linked to MOD-2021-311486 (Patient Link).
Patient reported severe myopathy/ myalgia resulting in the need of an emergency room visit/ referral to an orthopedic specialist.
Swollen lymph nodes in neck and under arm on the side with the vaccine (5 days following vaccination).; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 17:30 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included body mass index (more than 30) and superficial bloodclots. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medications within 2 weeks of vaccination. The patient previously received oxycodone (MANUFACTURER UNKNOWN) and experienced drug allergy. On 08Mar2021 at 06:30, the patient experienced swollen lymph nodes in neck and under arm on the side with the vaccine (5 days following vaccination). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes in neck and under arm on the side with the vaccine (5 days following vaccination) was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
@1212 Pt reported her face feeling flushed as well as very mild swelling to cheeks, itching to lips. Pt states that she does have a history of environmental allergies. Vitals @1229 143/73 HR 76 95% Room Air. Pt agreed to take Benadryl and 25mg (pt declined higher dose) was administered @1223. Pt provided with water and encouraged to drink water. After more observation time, pt stated she felt better and requested to leave with her daughter driving. Vitals @1242: BP 126/80 HR 76 O2 96% on room air. Pt was awake, alert and conversant throughout observation time. Pt and daughter educated on the side effects of Benadryl and made aware of the symptoms that would require them to call 911/respond to ED, both verbalized understanding and departed facility @ 1245. Pt was advised to speak to PCP regarding clearance for the 2nd dose of the COVID vaccine, pt verbalized agreement.
LA became severely painful, red & swollen about 3hr p/vax;reports problem worsened during noc;reports severe nausea, no vomiting s/s lasted approx 24hr;
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 03-MAY-2016, the patient was vaccinated with GARDASIL 9 (lot # L043213, expiry date: 23-AUG-2017) that was improperly stored. The vaccine was stored in refrigerator at a temperature of 14.2UC for 8 hours 30 minutes and at 1.5 UC for 26 hours 30 minutes and in freezer at a temperature of -12UC for 8 hours 30 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse effects reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Sx started evening after vaccine given. Temp 99.2. Severe headaches, muscular pain - generalized. Unable to lift affected arm with pain. Inj. site - tender to touch. Rx - Ibuprofen as needed, rest, fluids. F/U PM in 2 days.
The resident received the Pfizer Bivalent booster on 10/25/22 and then again on 11/9/2022. No adverse effects have been noted at this time.
Tired and foggy 4 hrs after injection. Muscle aches and weakness next morning with back pain and joint pain
Vértigo. Feeling very dizzy after receiving the vaccines. I especially feel this when standing up, moving. I do not feel this when lying down or sitting.  This symptom started at approx 6:30pm on Nov. 7, 2022 after receiving the vaccine at approx. 10:30am on Nov. 7, 2022. I did not have any side effects during the 15 minute period after the shots.
Extreme swelling of lips and face below the nose where Derm fillers had been administered back on October 7, 2021 (3 months prior) 30 hours after the booster. Treated with Methyprednisolone 4mg dose pack 21s, Advil and Zyrtec.